Effect of different oil on serum lipids

Phase 1

• Conditions: Hyperlipidemia.; Hyperlipidemia

• Registration Number: IRCT138905124497N1
• Lead Sponsor: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Normal HTN, no diabetes, no cardiovascular diseases
Exclusion criteria: TC=240mg/dl, TG=400mg/dl, LDL-C=160mg/dl, HDL-C=40mg/dl, body mass index (BMI) =35

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total Cholesterol. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;Triglyceride. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;LDL. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Calculating by Friedewald Formula.;HDL. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;Apoprotein A. Timepoint: Before and 40 days after the interventiondays. Method of measurement: Measurement (Autoanalyzer).;Apoprotein B. Timepoint: Before and 40 days after the intervention. Method of measurement: Measurement (Autoanalyzer).